Compare ARMP & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | FWRD |
|---|---|---|
| Founded | N/A | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.5M | 339.4M |
| IPO Year | 1996 | 2024 |
| Metric | ARMP | FWRD |
|---|---|---|
| Price | $7.58 | $13.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $15.00 | ★ $37.50 |
| AVG Volume (30 Days) | 60.6K | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.54 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,269,573,000.00 |
| Revenue This Year | N/A | $6.57 |
| Revenue Next Year | N/A | $6.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.74 | $7.86 |
| 52 Week High | $14.98 | $32.47 |
| Indicator | ARMP | FWRD |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 56.18 |
| Support Level | $7.22 | $9.47 |
| Resistance Level | $7.70 | $23.55 |
| Average True Range (ATR) | 0.68 | 0.86 |
| MACD | 0.06 | 0.72 |
| Stochastic Oscillator | 43.10 | 74.71 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.